Consensus Boston Scientific Corporation

Stocks

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - NYSE 16:00:02 2026-10-16 EDT			5-day change	1st Jan Change
44.39 ^USD	+0.57%		+3.88%	-53.45%

10-15	Baird Adjusts Price Target on Boston Scientific to $50 From $53	MT
10-14	Truist Securities Adjusts Boston Scientific Price Target to $51 From $57, Maintains Buy Rating	MT

Evolution of the Average Target: Boston Scientific Corporation

Evolution of the Target Price: Boston Scientific Corporation

Changes in Analyst Recommendations: Boston Scientific Corporation

ec059bad7.6GWCJZgRuC3c76JpNO3inPMepc-oyDDVNE7kKUDYJ6A.uyv3c_Rw1RutgJQMet_PxolZ-rn9jm-seAarTjmMEteyHLcd82X_SpCg-w~6eb41930432d2aef02ab902dbc23a211

Analysts' recommendations: Boston Scientific Corporation

10-15	Baird Adjusts Price Target on Boston Scientific to $50 From $53	MT
10-14	Truist Securities Adjusts Boston Scientific Price Target to $51 From $57, Maintains Buy Rating	MT
10-13	Mizuho Adjusts Price Target on Boston Scientific to $55 From $60	MT
10-09	Leerink Partners Adjusts Price Target on Boston Scientific to $55 From $60	MT
10-07	Evercore ISI Adjusts Price Target on Boston Scientific to $52 From $65	MT
10-05	Citigroup Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Neutral Rating	MT
10-02	Bernstein Adjusts Boston Scientific Price Target to $54 From $60, Maintains Outperform Rating	MT
09-24	Wells Fargo Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Equalweight Rating	MT
09-21	Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating	MT
09-17	Boston Scientific Shares Fall After Citigroup Downgrade	MT
09-17	Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57	MT
09-17	Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts Price Target to $50 From $57	MT
09-14	Bernstein Adjusts Price Target on Boston Scientific to $60 From $72, Keeps Outperform Rating	MT
09-10	Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating	MT
09-08	Boston Scientific Cyberattack Could Extend Rebound Timeline, Truist Says	MT
07-31	Argus Downgrades Boston Scientific to Hold From Buy	MT
07-30	Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says	MT
07-30	Leerink Partners Adjusts Boston Scientific Price Target to $60 From $74, Maintains Outperform Rating	MT
07-30	Wells Fargo Adjusts Boston Scientific Price Target to $50 From $55, Maintains Equal Weight Rating	MT
07-30	Bernstein Adjusts Boston Scientific Price Target to $72 From $76, Maintains Outperform Rating	MT
07-30	JPMorgan Adjusts Boston Scientific Price Target to $56 From $80, Maintains Overweight Rating	MT
07-30	UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating	MT
07-30	Baird Adjusts Price Target on Boston Scientific to $53 From $64, Maintains Outperform Rating	MT
07-30	TD Cowen Adjusts Price Target on Boston Scientific to $56 From $61, Maintains Buy Rating	MT
07-30	Jefferies Adjusts Price Target on Boston Scientific to $60 From $67, Maintains Buy Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BOSTON SCIENTIFIC CORPORATION					+33.46%
	THERMO FISHER SCIENTIFIC, INC.					+0.09%
	DANAHER CORPORATION					+6.59%
	INTUITIVE SURGICAL, INC.					+12.15%
	SIEMENS HEALTHINEERS AG					+9.52%
	EDWARDS LIFESCIENCES CORPORATION					+17.56%
	VEEVA SYSTEMS INC.					-4.29%
	AGILENT TECHNOLOGIES, INC.					+4.67%
	WATERS CORPORATION					+6.26%
	ILLUMINA, INC.					-8.19%
	Average					+7.78%
	Weighted average by Cap.					+6.99%